Doering; Christopher B.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Doering; Christopher B..The latest application filed is for "methods, devices and systems for enhanced transduction efficiency".

Company Profile

7.6.11

Doering; Christopher B. - Atlanta GA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods, Devices and Systems for Enhanced Transduction Efficiency App 20220184604 - Lam; Wilbur A. ; et al.	2022-06-16
Factor Viii Proteins Having Ancestral Sequences, Expression Vectors, And Uses Related Thereto App 20210388055 - Spencer; H. Trent ; et al.	2021-12-16
Expression of chimeric polypeptide with variable lymphocyte receptors on immune cells and uses for treating cancer Grant 11,136,369 - Spencer , et al. October 5, 2	2021-10-05
Factor VIII proteins having ancestral sequences, expression vectors, and uses related thereto Grant 11,046,750 - Spencer , et al. June 29, 2	2021-06-29
Recombinant Promoters And Vectors For Protein Expression In Liver And Use Thereof App 20210128751 - Doering; Christopher B. ; et al.	2021-05-06
Recombinant promoters and vectors for protein expression in liver and use thereof Grant 10,898,588 - Doering , et al. January 26, 2	2021-01-26
In Utero Transplantation Of Factor Viii-expressing Cells For Treatment Of Hemophilia App 20200368286 - Almeida-Porada; Maria Graca N.D. ; et al.	2020-11-26
Post-natal Transplantation Of Factor Viii-expressing Cells For Treatment Of Hemophilia App 20200360441 - Almeida-Porada; Maria Graca N.D. ; et al.	2020-11-19
Cas9 Nucleic Acid Molecules And Their Use App 20200299722 - Doering; Christopher B. ; et al.	2020-09-24
Factor Viii Proteins Having Ancestral Sequences, Expression Vectors, And Uses Related Thereto App 20200277356 - Spencer; H. Trent ; et al.	2020-09-03
CAS9 nucleic acid molecules and their use Grant 10,724,050 - Doering , et al.	2020-07-28
Expression of Chimeric Polypeptide with Variable Lymphocyte Receptors on Immune Cells and Uses for Treating Cancer App 20190256574 - Spencer; H. Trent ; et al.	2019-08-22
Expression of chimeric polypeptide with variable lymphocyte receptors on immune cells and uses for treating cancer Grant 10,323,077 - Spencer , et al.	2019-06-18
Recombinant Promoters And Vectors For Protein Expression In Liver And Use Thereof App 20180344877 - Doering; Christopher B. ; et al.	2018-12-06
Recombinant promoters and vectors for protein expression in liver and use thereof Grant 10,058,624 - Doering , et al. August 28, 2	2018-08-28
Recombinant Promoters And Vectors For Protein Expression In Liver And Use Thereof App 20170326256 - Doering; Christopher B. ; et al.	2017-11-16
Expression of Chimeric Polypeptide with Variable Lymphocyte Receptors on Immune Cells and Uses for Treating Cancer App 20170008947 - Spencer; H. Trent ; et al.	2017-01-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.